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Abstract
The removal of the eyeball with or without other orbital tissues is always a complicat‐
ed decision to take and nearly always involves the beginning of a new and intense
doctor-patient relationship. The loss of the globe results in the loss of binocular vision
and depth perception, thus the patient is limited when applying for certain jobs or
handling delicate or dangerous materials. They may also be prohibited to drive in
some countries o may have to do so with special care where permitted. The psycho‐
logical impact on the patients´ life may be even greater as it may be perceived as a
severe facial disfiguration. Some patients may prefer to stay at home and their social
life may be deeply affected. Since facial and eye appearance is essential for normal hu‐
man relations and interaction, prosthetic eyes or orbits should imitate the eye, in most
cases, or the whole orbit-eyelids-eye complex, which is less frequent.
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1. Introduction
The need to remove an eye or other orbital contents is always difficult to digest for a patient.
Many of them will experience the five stages of grief described by the Swiss psychiatrist
Elisabeth Kübler-Ross in her 1969 book [1] On Death and Dying, inspired by her work with
terminally ill patients. Older patients may think that these kinds of surgeries, especially
exenteration, are not worth it. Younger patients are usually very worried about the cosmetic
result rather than the difficulty of the surgery and the postoperative period. The ophthalmol‐
ogist will need a good dose of empathy and psychology skills to explain to the patient that the
planned surgery is the only and best option. The oculoplastic surgeon must be ready to hear
that some patients will wish to ask for a second opinion. This may annoy the doctor in charge
of the patient, but despite of this, it is advisable to help the patient look for a second opinion
with other colleagues. When dealing with these kinds of patients, it is crucial to take your time
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to explain with detail the surgical technique, the time the patient is expected to stay in the
hospital, the need for frequent bandage changes in the hospital clinic, the possible complica‐
tions of the socket, and a long recovery period before a prosthesis can be fitted in.
Evisceration, enucleation, and exenteration are the three main surgical options. Evisceration
is the removal of the contents of the globe while leaving the sclera and extraocular muscles
intact. Enucleation is the removal of the eye from the orbit while preserving all the other orbital
structures, and exenteration is the removal of the globe as well as the soft tissues of the orbit
(connective tissue, fat, and muscles).
There is evidence that Egyptians and Sumerians used artificial eyes to decorate their mummies
and their statues, respectively; however, there is no evidence to suggest that they used them
for medical purposes in living people. Clay models resembling eyes were used in the Roman
Empire around 500 BC to cover phthisical eyes. It was not until the 16th century that enuclea‐
tion surgeries were reported in the medical literature. In 1583, George Bartisch first described
the extirpation of an eye. In 1817, Bear introduced evisceration in an eye with an expulsive
hemorrhage when performing an iridectomy for an acute glaucoma [2].
It was in 1874 when Noyes reported the routine evisceration of the ocular contents when there
was severe intraocular infection [3]. Later, in 1884, Mules reported for the first time the use of
an orbital glass sphere implant in an eviscerated cavity, this becoming the bedrock of volume
loss restoration and improving dramatically cosmetic results of this surgery [2,4]. In 1887, Frost
inserted a crystal ball orbital implant inside Tenon’s capsule after an enucleation procedure [5].
Since then, advances in surgical techniques, anesthesia, new implants, and wrapping materials
and prosthetics over the past decade have greatly improved surgical outcomes and patient
satisfaction. Today, most patients have good cosmetic results following the removal of and
eye. However, even an exquisite surgical technique cannot prevent complications in the
immediate and long-term follow-up of these sockets, making these patients challenging for
the Oculoplastic Surgeon.
The decision to remove an eye must be individualized to each patient. Advantages and
disadvantages exist among the different surgical techniques and implant materials.
2. Surgical indications
2.1. Enucleation
The most common indications are intraocular malignancy, blind painful eyes, penetrating
trauma, very bad ocular cosmesis or phthisical eyes, and prevention of sympathetic ophthal‐
mia (SO).
A significant decrease in the number of enucleations was observed between 1975 and 1995.
This was primarily caused by a decrease in the number of glaucoma-related enucleations [6].
Evisceration, unlike enucleation, disrupts the integrity of the globe’s barriers, which could
trigger an autoimmune reaction (SO) in the contralateral eye. Although some authors believe
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that SO continues to be an important disadvantage, evisceration has gained popularity in the
past few decades because of superior functional and cosmetic results compared to enucleation.
Levine et al. [7] concluded that the risk of SO following evisceration is extremely low.
Choroidal melanoma in adults and retinoblastoma in children are the most common intraoc‐
ular malignancies. In some cases of malignancy diathermy, chemotherapy and radiation may
be an alternative to more disfiguring surgeries.
2.2. Evisceration
1. Penetrating trauma: one of the most common indications of evisceration in cases when
sclera is largely intact.  Classically, it  was thought that surgery should be performed
within 14 days of injury. In cases with extensive disruption of the globe’s tissues, the
removal of all uveal tissue is difficult via an evisceration; therefore, enucleation may
be a better option [6].
2. Blind eyes: removal of a blind eye is generally the last possibility. We attempt to control
pain with a retrobulbar injection of alcohol or chlorpromazine. When the patient refers
corneal discomfort, some eyes may benefit from conjunctival flaps [8]. Nowadays
evisceration is widely preferred in Europe because of its advantages in blind eyes, such
as better cosmetic results and shorter postoperative recovery time [9].
3. Endophthalmitis: many surgeons prefer evisceration for endophthalmitis because of the
low risk of bacterial retroocular space invasion. Others suggest that enucleation should
be performed when there is no certainty that the sclera may be involved [10]
2.3. Exenteration
Orbital  content  removal  is  reserved  for  the  treatment  of  potentially  life-threatening
malignances  arising  from  the  eye,  eyelid,  orbit,  paranasal  sinuses,  and  periocular  skin.
Secondary orbital spread from eyelid, intraocular, and conjunctival malignant tumors was
the most frequent indication of exenteration, followed by primary orbital malignant tumors.
Other indications have included sclerosing inflammatory pseudotumors and invasive fungal
disease of the orbit [11-13].
3. Surgical techniques
3.1. Enucleation surgical technique
1. It is absolutely mandatory to ensure we will remove the correct eye. Sometimes it is
obvious which eye should be enucleated, like in a severely traumatized eye, but in other
cases, the eye can be morphologically perfect and doubts can arise. This can be the case
of a choroidal melanoma. We strongly recommend to read the patients notes and ask the
patient to identify the eye that should be removed. Once sure, the eye should be marked
with pen with an arrow or letters on the side of the forehead of that eye. We also like to
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dilate the eye with tropicamide [14]. This marks the side to operate on and allows the
surgeon to check the tumor inside the globe in the operating room.
2. Once in the operating room, we ask the patient to identify calling out his name and
surname and age. We ask again which eye is the one to be removed and to signal it for us
with his hand before he lies on the operating table.
3. Although we are aware some surgeons prefer intravenous sedation and local anesthesia,
it is of our preference and of our patients to undergo general anesthesia. Even in cases of
general anesthesia, some surgeons also inject local anesthesia so as to obtain local
vasoconstriction, which will aid the surgeon making the surgery “cleaner” and faster. Two
percent lidocaine with 1:100,000 epinephrine can be used for superficial injection like in
the subconjunctival space. Retrobulbar anesthesia is made with a combination of 2%
lidocaine and 1:100,000 epinephrine mixed 1:1 with 75% bupivacaine.
4. Intravenous antibiotic is usually used 30 min prior to surgery in the presurgery prepara‐
tion area.
5. We prep and drape in the standard fashion using povidone iodine for the skin and
conjunctiva. We like to cover the other eye, but some may prefer to let the other eye
uncovered and closed.
6. We use a lid speculum, taking care to protect the field from eyelashes. If eyelashes enter
the field, these can be cut or stuck to the eyelid with an adhesive skin closure.
7. Using Westcott scissors or dissection scissors, perform a 360° limbal peritomy trying to
leave on the limbus no more than 1 mm of conjunctiva. Remember to be as careful as
possible. The conjunctiva, once closed at the end of the surgery, will be the first defensive
layer of the anopthalmic socket (Figure 1).
Figure 1. 360° limbal peritomy
8. Blunt dissect Tenon’s capsule from the globe. Introduce your dissection scissors beneath
the conjunctiva and Tenon in the limbus in any of the four quadrants limited by the four
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rectus muscles and smoothly direct your dissection posteriorly and around the globe until
you feel you are close to the optic nerve. Repeat this maneuver in the other three quadrants
(Figure 2).
Figure 2. Blunt dissection of Tenon´s capsule
9. Localize each rectus muscle with one or two muscle hooks. Ensure you isolate the insertion
of the muscle. If this is not visible, some Tenon tissue may be present. Remove it with
blunt forceps, pulling it away from the muscle insertion (Figure 3).
Figure 3. Muscle insertion isolation
10. Pass a 5/0 absorbable suture in a whiplock fashion on either side of the muscles insertion.
Cauterize with a monopolar (Colorado needle) or bipolar cautery to avoid bleeding and
Eye Removal — Current Indications and Technical Tips
http://dx.doi.org/10.5772/61030
29
then cut the insertion of the muscle with a scissor leaving 1 or 2 mm of insertion on the
globe (this stump will be useful in the future to pull the eye out of the orbit). Clamp the
sutures for the four rectus muscles away from the surgical field with bulldog clamps or
hemostats. The muscles will “spread” away from the globe (Figures 3-5).
Figure 4. Muscle insertion is cut
Figure 5. Four rectus muscles are isolated
11. Isolate the inferior oblique muscle in the inferotemporal quadrant with a muscle hook
sweeping it from posterior to anterior toward where the inferior rectus was located. As
with the rectus muscles, cauterize and cut. Some surgeons like to reinsert the inferior
oblique muscle in the orbital implant. In our experience, it is not necessary to achieve a
correct implant motility (Figure 6).
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Figure 6. Inferior oblique exposure
12. Isolate the superior oblique muscle in the superonasal quadrant by sweeping the muscle
hook from anterior to posterior toward the insertion of the superior rectus muscle.
Cauterize, cut, and leave untagged.
13. Pass a 4/0 silk suture through the insertion of the two horizontal rectus muscles or the
four of them. This will help to pull the globe during the removal.
14. Place a hemostat around the optic nerve. This will prevent the ophthalmic artery from
bleeding. Place a large curved hemostat behind the globe; thus, you can safely cut the optic
nerve with scissors without danger for the integrity of the globe. When you cut the nerve,
you will find it harder than you would expect. To get as much optic nerve stump as
possible, try to direct the scissors posteriorly while pulling the globe out of the orbit with
your traction sutures (Figures 7 and 8).
Figure 7. Hemostat placed on optic nerve which is cut with scissors
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Figure 8. Sagital view of the orbita showing the optic nerve being cut
15. Once the nerve is cut and you pull with your silk sutures, you may feel something is
retaining the globe in the orbit. It is usually small segments of retained Tenon’s capsule.
Cut this Tenon’s tissue with care as it may contain small vessels that may bleed. We
recommend you cut this tissue as close to the globe as possible in order to avoid inadver‐
tent injury to other tissues like muscles or orbital fat (Figure 9).
Figure 9. Globe removed from the orbit. Optic nerve stump compressed by hemostat
16. Place the globe in an auxiliary table and prepare it to send to the pathologist.
17. Release the hemostat around the stump of the optic nerve. Apply pressure in the socket
and coagulate the optic nerve with the monopolar or bipolar cautery if there is generous
bleeding. Avoid excessive cauterization in the socket as it may predispose to future
complications of the cavity such as its contraction or implant displacement. Sometimes
gentle pressure with gauze soaked in thrombin, saline, or hydrogen peroxide for a few
minutes is enough to stop small hemorrhages.
18. Once the socket is ready, the next step is to introduce the orbital implant. The size of which
should have been chosen depending of the axial length of the eye or the fellow eye if the
removed eye was in phthisis.
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19. Nonporous implants should be implanted, wrapped in a mesh or donor sclera; porous
implants can be implanted, wrapped or unwrapped.
20. Prior to insertion of the implant, it is immersed in an antibiotic solution (500 mg of
cefazolin in 500 ml of saline). Then a Vicryl mesh or sclera is placed around de implant.
If you use a mesh, twist the excess mesh in the posterior pole of the implant, tie a knot
with 4/0 polyglactin suture, and cut the remaining material. If you use donor sclera, suture
it around the implant with 5/0 silk.
21. The implant is then introduced within Tenon’s capsule in the orbit. Some surgeons use a
Carter sphere introducer or similar plunger-like mechanisms. We use our hands. It is of
crucial importance in order to avoid future problems to place the implant as posterior as
possible. This is in the intraconal space, leaving part of the posterior pole of the implant
uncovered by Tenon’s capsule. Sometimes Tenon’s tissue is dragged as you introduce the
implant. We recommend that the surgical assistant retracts Tenon’s anteriorly so as to
avoid its displacement with nontoothed forceps while placing the implant.
22. Once correctly positioned in the orbit, we press the implant deep in the orbit with a finger
to make sure it is correctly fitted. Make sure that Tenon’s layer is not trapped under the
implant and that it covers the implant needing no excessive traction with nontoothed
forceps. If any doubt of good positioning or implant size should arise, removal of the
implant is always a good option.
23. Secure the rectus muscles on the anterior surface of the implant or on the wrapping
material. We like to suture first the horizontal rectus muscles. Avoid overlapping of the
muscles. Some authors recommend a 5-to-10mm distance between them. We believe that
placing them next to each other helps preventing implant extrusion. In the same way,
suture both vertical rectus muscles adjacent to the horizontal muscles, creating a “muscle
barrier.” You may want to suture the inferior oblique muscle just inferior to the lateral
rectus muscle (Figures 10 and 11).
Figure 10. Sagital view of the orbit showing four rectus muscles sutured to the implant
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Figure 11. Frontal view of the orbit showing four rectus muscles sutured to the implant
24. Meticulous closure of Tenon’s capsule is very important. We recommend interrupted
buried 5/0 absorbable (polyglactyn) sutures, but some may prefer a running suture. It is
extremely important to avoid tension when closing Tenon’s layer (Figure 12).
Figure 12. Tenon´s capsule sutured beneath conjunctiva
25. A running 6/0 absorbable suture is used to close the conjunctiva, once again, avoiding not
too close tissue under tension. Nerad [14] recommends local anesthetic injection into the
retrobulbar space for postoperative pain relief (Figure 13). We prefer intravenous
analgesia.
26. Abundant antibiotic and steroid ointment should be placed in the socket, and finally an
acrylic conformer should be placed. Some surgeons perform a temporal tarsorrhaphy to
maintain the conformer in place for 1 or 2 weeks.
27. Tight application of eye patches will finish our surgery.
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3.2. Evisceration surgical technique
1. See enucleation surgical technique (Figure 1).
2. Undermine the conjunctiva by approximately 5 mm, 360°.
3. Blunt dissect Tenon’s capsule from the globe. Introduce your dissection scissors beneath
the conjunctiva and Tenon’s layer in the limbus in any of the four quadrants limited by
the four rectus muscles and smoothly direct your dissection posteriorly and around the
globe until you feel you are close to the optic nerve. Repeat this maneuver in the other
three quadrants (Figure 2).
4. Localize each rectus muscle with one or two muscle hooks. Ensure you isolate the insertion
of the muscle. If this is not visible, some Tenon tissue may be present, remove it with blunt
forceps pulling it away from the muscles insertion (Figure 3).
5. Pass a 5/0 absorbable suture in a whiplock fashion on either side of the muscles insertion.
Clamp the sutures for the four rectus muscles away from the surgical field with bulldog
clamps or hemostats (Figure 14).
6. Incise full thickness of the cornea at the limbus with a blade (numbers 11 and 15; Phaco
Keratome). Note that aqueous humor will exit the anterior chamber. Complete a 360°
keratectomy with Westcott scissors and toothed forceps (Figure 14).
7. Once the cornea is removed, use an evisceration spoon to dissect the sclera from the
choroid. If complete dissection is possible, remove the intraocular contents en bloc. It is
common to find active bleeding from the central retinal artery and other perforant arteries
that branch from long anterior ciliary arteries. We recommend to use suction and a
monopolar or bipolar cautery to stop the bleeding. Should the intraocular contents break
while dissecting the choroid from the sclera, we recommend to remove them with a
suction device in order to minimize the exposure of the content of the eye to the socket,
thus reducing the low risk of sympathetic ophthalmia (Figure 15).
Figure 13. Conjunctiva sutured under an acrylic conformer
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Figure 15. Choroid is dissected from sclera
8. Wipe the internal scleral surface with cotton-tipped applicators soaked in absolute alcohol
and remove retained uveal tissue with gauze.
9. Upon this point of the surgery, there are different options to prepare the sclera to accom‐
modate the orbital implant. Some authors prefer to make 10-15 mm radial scleral incisions
in the four oblique quadrants, avoiding the insertions of the rectus muscles [13]. Others
prefer a complete posterior sclerotomy, transecting the sclera from the superior nasal and
inferior temporal limbus to the optic nerve. Sclera is then trimmed from the optic nerve
in a circular fashion. We prefer the four-petal technique described by Sales-Sanz and Sanz-
Lopez [15]: four sclerotomies are performed from the limbus, between the rectus muscle
insertions, to the optic nerve with Stevens scissors. The optic nerve is cut at its insertion
Figure 14. Keratectomy is started with number 15 or number 11 blades
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point in the posterior sclera. The four sclerotomies reach one another to form four separate
scleral petals, each containing one rectus muscle insertion. This last option allows in our
experience an easier insertion of the orbital implant in the intraconal space and secondarily
makes complete cover of the implant very simple (Figure 16).
Figure 16. Four sclerotomies performed with scissors
10. 9. Gently pull the four petals out of the socket so the implant can be placed as deep as
possible using a Carter sphere introducer or your fingers. The further the implant enters
the orbit, the easier it will be to bring the four petals anterior to the implant. Because the
petals are independent from each other and from the optic nerve, the sclera can cover any
size of implant without tension. The vertical petals are sutured to each other in front of
the implant using a continuous 5/0 absorbable suture. The horizontal petals are sutured
in the same way over the vertical petals. Make sure that sutures are tied with no tension
(Figures 17-20).
Figure 17. Four petals stretched wide appart
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Figure 18. Impant placed between petals pressed deep inside the orbit
Figure 19. Implant wrapped with sclera from the upper and lower petals with muscles attached
11. Meticulous closure of Tenon’s capsule is very important. We recommend interrupted
buried 5/0 absorbable (polyglactyn) sutures; again, some may prefer running sutures. It
is extremely important to avoid tension when closing Tenon’s layer (Figure 12).
12. A running 6/0 absorbable suture is used to close the conjunctiva, once again avoiding to
close tissue under tension (Figure 13).
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13. Abundant antibiotic and steroid ointment should be placed in the socket, and finally an
acrylic conformer should be placed. Some surgeons perform a temporal tarsorrhaphy to
maintain the conformer in place for 1 or 2 weeks.
14. Tight application of eye patches will finish our surgery.
3.3. Exenteration technique
Technically, orbital exenteration has several variations, each with its own indications.
3.4. Total exenteration
1. General anesthesia is advisable. Local anesthesia is useful to achieve good hemostasis in
the eyelid and periorbital tissues. Retrobulbar or intraorbital anesthesias are forbidden
when tumors or infections are present.
2. Intravenous antibiotic is usually used 30 min prior to surgery in the presurgery prepara‐
tion area.
3. 4/0 silk sutures (two per eyelid) are placed on the eyelid border to provide traction. We
recommend long bits with the needle as traction later on in the surgery may tear the tarsal
and skin tissues.
4. With a scalpel blade (number 11 or 15) or with an electrocautery, incise the skin in an
elliptical fashion trying to follow the inner surface of the orbital rim (Figure 21).
5. Dissect under the skin until you reach the periorbita with scissors or with the electrocau‐
tery. We strongly recommend to have a bayonet bipolar cautery forceps and a suction
device before entering the subperiosteal space (Figure 22).
Figure 20. Sagital view of orbit showing correct wrapping of implant with four petals of sclera
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Figure 22. Skin incisión with number 11 or number 15 blades following the inner surface of the orbital rim
6. Once the periorbita is reached, incise it with a scalpel blade, a monopolar cautery, or a
Freer periosteal elevator. Sometimes it is difficult to elevate the periorbital periostium as
it is firmly stuck to the underlying bone, especially in the frontal bone and the frontal
process of the maxillary bone (Figure 23).
Figure 23. Detail of the periorbita being incised. Note ROOF being rejected temporally and lateral tarsal ligament being
rejected nasally
Figure 21. Frontal view of implant wrapped in scleral petals with attached rectus muscles
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7. Once elevated the periorbital periostium, continue elevating the orbital periosteum. Care
should be taken where the periosteum is more tightly adhered to the bone: anterior and
posterior lacrimal crests, insertion of the inferior oblique muscle, trochlea, lateral orbital
tubercule, and superior and inferior orbital fissures (Figure 24).
Figure 24. Freer periostal elevator dissecting periorbita
8. Periosteum should elevate easily with the help of the Freer periosteal elevator and
malleable retractors. At some point, periosteum can tear, do not panic, and carefully try
to dissect it from the opposite point of the tear. The nasolacrimal duct will be exposed
once the periosteum is elevated. If possible, obliterate it with fat or muscle to decrease the
risk of fistula formation.
9. Continue posterior dissection of the periosteum. At this point, you should remember the
orbital anatomy, a squared based pyramid. This means you will need to use your traction
sutures on the eyelids and help yourself with one or two small malleable retractors to
displace the orbital contents in order to increase the visibility of the orbital walls.
10. Important landmarks to take into account and to avoid damaging are as follows: in the
medial wall—supratrochlear and anterior and posterior neurovascular bundles; in the
roof—supraorbital neurovascular bundle; in the lateral wall—zygomaticofacial and
zygomaticotemporal neurovascular bundles; and in the floor of the orbit—the infraorbital
canal. When you come across these structures, bipolar cautery should be applied. Some
authors prefer to clip them (Figures 25 and 26).
11. It is also important to remember that the medial wall and the floor of the orbit are easy to
break because the bones at those points are thin, especially in the lacrimal fossa and in the
ethmoid bone’s lamina papyracea.
12. When dissection progresses in the inferolateral portion of the orbit, we will encounter the
infraorbital fissure that is rich in vessels. It should be thoroughly electrocauterized.
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13. Continue the dissection until the apex is reached. Carefully cauterize the superior orbital
fissure and the posterior orbital tissues, including the optic nerve. We recommend to be
patient and slowly cauterize and cut in small bits to avoid bleeding that may be difficult
to control and may frighten the surgeon (Figure 27).
Figure 27. Sagital view of Freer periostal elevator dissecting the periorbita posteriorly
Figure 25. Dissection is carried on deep back towards the orbital apex
Figure 26. Avoid damaging important vessels such as the Anterior Ethmoidal Artery
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14. Pull the silk traction sutures and place the orbital content in an independent table where
it will be prepared to be sent to the pathologist.
15. The orbit with the bare bones may be left to granulate, gauzes with antibiotic should be
placed, and the orbit should be pressure patched. Some authors will consider covering
the bone with a split-thickness skin graft [11,14,16] from the thigh or a tissue flap, generally
from the temporalis muscle (Figures 28 and 29).
Figure 28. Frontal view of the exenterated orbit showing bone landmarks and hemostasis of the orbital apex
Figure 29. Medial view of the exenterated orbit showing bone landmarks and hemostasis of the orbital apex
3.5. Eyelid-sparing exenteration
We prefer this procedure when the disease does not affect the eyelid because the skin and
orbicularis muscle can be used as “primers” to initiate the cavity’s granulation and epitheli‐
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alization. The difference with the previously described technique is that the skin incisions are
placed 2 mm above the lash line and are joined at the medial and lateral canthus. Dissection
is carried out in the preseptal plane or in the preorbicularis plane. We prefer the preseptal
plane; it is easy to follow and allows a good blood supply to the future granulation tissues.
In conclusion, with this procedure, we partly cover the orbital bones, and we add a vascular
supply to our skin flap, reducing the time the socket needs to granulate.
3.6. Subtotal exenteration
It may be performed when the disease involves anterior orbit or conjunctiva as in conjunctival
melanoma or sebaceous cell carcinoma without evidence of deep orbital invasion. It spares
orbital tissues from the deep orbit; thus, the socket should heal earlier, but orbital prosthesis
fixation can be complicated since there is less space.
The technique is similar to that of total exenteration but subperiosteal dissection is not carried
out as far posteriorly. Orbital tissues are cut, and thorough hemostasia is performed.
3.7. Extended exenteration with bone removal
Unfortunately, high-grade malignancies or osteolytic processes will require total exenteration
and the removal of the bones of the orbit. Help from other surgeons such as neurosurgeons,
otolaryngology, or maxillofacial surgeons is mandatory in these cases.
3.8. Reconstruction of the exenterated orbit
The decision to reconstruct the exenterated socket depends on what is planned for that orbit.
When the patient desires an orbital prosthesis, spontaneous epithelialization, skin grafts, or
thin local flaps are good options. Some surgeons argue that spontaneous granulation permits
a better follow-up of the cavity in order to treat as soon as possible if disease recurs. Others
prefer to fill the cavity with temporalis muscle flap but this increases the difficulty to adapt an
orbital prosthesis for the ocularist.
3.9. Spontaneous granulation
It is the fastest way to finish the surgery, and it reduces surgical morbidity in other sites but
requires very frequent postsurgical care, initially three times a week and later on every 1 or 2
weeks until complete epithelialization is observed. This can take up to 2 or 3 months more than
when split thickness grafts are used. Usually, gauzes with antibiotic ointment are applied in
the first month.
3.10. Skin grafting
Split thickness grafts, usually harvested from the thigh with an automated dermatome, are
used, which is technically simple to perform and takes less time than a more complex flap
reconstruction. In order to adapt the graft to the socket, slits can be performed with scalpel or
a number 15 blade. The edges are sutured to the borders of the surgery with absorbable 6/0
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sutures. Gauze soaked in antibiotic ointment is packed in the socket, and a pressure dressing
is placed for 1 week. Once this is removed, the gauze will be changed every 2 or 3 days until
the graft is correctly stuck to the bone beneath.
3.11. Soft tissue reconstruction
Some surgeons advocate primary reconstruction during exenteration surgery. Volume loss in
the socket can be replaced with vascularized free flaps. They are useful to cover alloplastic
implants or other kind of flaps used for bony reconstruction. One of their disadvantages is
donor site morbidity. Another one is that aesthetics in the donor site and the socket may seem
unnatural. Many local flaps have been used, including temporoparietal fascia, temporalis
muscle, or frontalis muscle. As said previously, these flaps can potentially affect postoperative
tumor surveillance, making imaging techniques, especially MRI, essential and increasing the
cost for the National Health Service or the insurance company. On the other hand, orbital
obliteration with a flap reconstruction may confer less pain, improve personal hygiene, and
reduce the risk of sino-orbital fistula formation [17]. Spiegel et al [18] reported that orbital
obliteration reduces the risk of intracranial infections and facilitates dosage calculation of
radiotherapy by providing a more consistent and predictable tissue density.
3.12. Rehabilitation of the socket
Once exenterated, eviscerated, or enucleated, the socket is perceived by the patient and the
family as a very significant facial deformity. Initially, the simplest way to mask the socket is
with eye patches. However, once the cavity has healed, the patient can benefit from the
experience of an ocularist.
Enucleated or eviscerated cavities will have a temporal prosthesis fitted in 4 or 6 weeks after
surgery. Later on, a prosthesis will be made using a modified impression technique, so a
custom-made prosthesis will be designed and adapted at the ocularist. It is very common that
artificial eyes need to be adapted several times after the initial fitting before the patient feels
comfortable with them. The patient will be followed at the ocularist once or twice a year to
check if the prosthesis fits correctly in the socket, if it is affecting the lower eyelid (the weight
of the prosthesis is a key factor) or if its surface needs polishing. The ophthalmologist will
check the prosthesis position, the presence or absence of discharge, whether the fornices look
normal, how the superior sulcus is, eyelid malpositions, eyelash malposition, relative enoph‐
thalmos, etc., when the patient visits the clinic.
Exenterated orbits are more difficult to deal with. Orbital prostheses are made by experienced
anaplastologists or ocularists. The material used is completely different, usually silicone. Some
patients may find glasses useful to mask the skin silicone interface. Sometimes, especially in
shallow orbits, the prosthesis may tend to fall; therefore, magnetic coupling with osseointe‐
grated screws can be fitted in, typically several months after epithelialization of the orbit is
complete. Unfortunately, some patients might find that the lack of movement of these
prostheses may make other people feel uncomfortable, and prefer to use just an eye patch.
Eye Removal — Current Indications and Technical Tips
http://dx.doi.org/10.5772/61030
45
4. Orbital implants
Evisceration and enucleation result in an empty cavity and aesthetic problems for the patients
that we should try to avoid. We must be sure that the patient fully understands the information
given about the surgery and expected results in order to obtain the informed consent. Once
this is done, the surgeon will decide the type of orbital implant, which can be placed primarily
or secondarily in another surgery. The implant can be made of synthetic material, autologous
material, or eye-banked tissues. The ocularist has a very important role in the aesthetics of the
patient. Artificial eyes have enormously improved the psychological impact and the physical
image of the person who undergoes this mutilating surgery. It was back in 1885 when Mules
suggested the idea of placing orbital implants in these orbits [4]. Later on, Frost used hollow
glass spheres as orbital implants. The surgical procedure was slightly modified with time. It
was not until 1972 when Soll [19] suggested placing the implant beneath Tenon’s capsule.
Helveston covered the implant with donor sclera. The volume loss in some sockets, the
presence of contracted sockets, or the implant extrusion made Smith and Petrelli propose the
use of dermis-fat grafts in some patients. The ideal implant should fulfill these requirements:
it should replace enough orbital volume, it should permit the artificial eye to move as much
as possible, it should make the eye prosthesis fit adequately in the socket, it should have a low
complication rate, it should be cost-effective and simple to implant in the orbit, biocompatible,
and it should not degrade [20].
Herein, we will review the available types of implants. Bio-inert and nonporous materials have
given way to porous materials. The latter have multiple micropores that are interconnected,
mimicking the human bone trabecular meshwork. Complications after orbital implantation
will depend on several factors, including the surgical technique, the material and size of the
implant, previous orbital treatments (e.g., radiotherapy), orbital disease, poorly fitted artificial
eyes, or infections.
4.1. Implant selection
Both evisceration and enucleation can be performed without orbital implants, but nowadays,
it is very rare not to use them because of the very poor esthetic results. The goal of placing an
implant in the orbit is to compensate the loss of volume, to improve the prosthesis motility,
and to offer a good symmetry with the contralateral eye. Some considerations on these facts
are as follows:
4.2. Replacing volume loss
Volume loss appears to be the main determinant of anatomic changes after enucleation [21].
Human radiographic studies have confirmed that placing a spherical implant within Tenon’s
capsule counteracts the rotation of intraorbital contents after enucleation and associated back-
tilt of the prosthesis. An adequate volume replacement permits a thinner prosthesis, relieving
weight on the lower eyelid and minimizing associated ectropion formation and lid laxity [22].
Furthermore, an inferior displacement of the superior rectus-levator complex is associated to
those changes [23]. Therefore, the implant must be big enough to replace the volume loss but
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not too big, which may create excessive tension on Tenon’s capsule that could favor the implant
extrusion.
Proper implant size can be calculated either preoperatively (from the axial length of the eye to
be operated on or the fellow eye) or intraoperatively (determining the volume of fluid
displaced by the enucleated eye in a graduated cylinder). We recommend the first option.
Kaltreider et al. [24] showed that the implant diameter should be the eye’s axial length minus
2 mm or minus 1 mm if the length was calculated with A-scan. An implant that is too small
will need a bigger prosthesis, potentially resulting in lower eyelid laxity and malposition of
the artificial eye. Larger than needed implants will require smaller prosthesis but are associated
to higher exposure rates and may difficult the adaptation of the artificial eye [25]. We follow
the recommendations from Jordan and Klapper for adult patients. These are 20-22 mm
spherical implants in enucleation surgery and 18-20 mm spherical implants in evisceration
surgery [16].
4.3. Maintaining levator function
Another important issue to consider is the functionality of the levator muscle of the upper lid.
The smaller diameter of implant, as compared to the globe alters the functional length and
pivot point of the superior rectus-levator complex [26]. These factors may lead to a decreased
levator function and ptosis. This situation can be improved either by surgery or by adding to
the superior margin of the prosthesis additional material.
We should remember that with time, the orbital tissues of an anophthalmic orbit tend to
contract towards the orbital apex, that is, nasally and inferiorly [27].
We can consider orbital implants in two main groups: integrated and nonintegrated implants.
4.4. Nonintegrated implants
They do not have a surface where rectus muscles can be anchored, nor they allow fibrovascular
tissue to grow in them (this is why we call them nonintegrated). They include implants made
of glass, rubber, iron, acrylic material, silicone, gold, silver, or polymethylmethacrylate [28].
Their only function is to replace the volume loss and to improve the cosmetic result. If the
surgeon wants to increase the motility of the implant and, consequently, of the prosthesis, the
rectus muscles should be repositioned and sutured to the anterior pole of the implant in order
to move the artificial eye when the implant moves. Unfortunately, the movements achieved
with this method are of smaller range than dose achieved when the implant is pegged. Some
authors have suggested that when the rectus muscles are placed as described previously, that
is, in the anterior pole of the implant, it may migrate when the muscles contract. Mourits et al.
[29] consider that acrylic implants have a low extrusion rate and are easier to implant and
explant (their surface is smoother, and there is no fibrovascular ingrowth to retain the implant)
and are cheaper than porous implants. Nonintegrated implants have been widely used and
have achieved good results in the end of the 19th century and all over the 20th century.
Nowadays, they are still used in patients over 70 years old.
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4.5. Integrated implants
4.5.1. Hydroxyapatite
Coralline hydroxyapatite is used frequently in enucleation surgery. It began to be used in
orbitary implants in the 1980s. It is a calcium phosphate salt present in the human bone. It is
considered to be nontoxic, nonallergenic, and biocompatible. It allows fibrovascular tissue to
grow in the implant, thanks to its 3-D architecture [30]. If the fibrovascular growth is poor,
there is a risk of implant extrusion. There are two commercially available implants: Bio-Eye
(Integrated Orbital Implants, Inc., San Diego, CA) and M-Sphere (IOP, Inc., Costa Mesa, CA).
Bio-eye has been the first choice for many surgeons for years. In a survey performed in 2002
with the oculoplastic surgeon members of the American Society of Ophthalmic Plastic and
Reconstructive Surgeons (ASOPRS), they inquired about their preferences in primary enu‐
cleations; 27.3% used hydroxyapatite while 42.7% used porous polyethylene [31]. Jamell et al.
[32] suggested that the best way to evaluate fibrovascular growth into the implant is contrast-
enhanced magnetic resonance with surface coil. They were able to show early fibrovascular
growth in the implant being the central ingrowth of the fibrovascular tissue slower. This
evaluation of the central vascularization of the implant is of great importance in order to know
when to peg the implant. The greater vascularized the implant, the bigger the risk of blood
when the implant is drilled, but at the same time, it is believed to reduce to the risk of infection,
exposure, and migration [32,33]. Nevertheless, this technique has its drawbacks; it is time
consuming and expensive. Therefore, sometimes you cannot detect complications of the
vascularized implant on time. Due to this, Qi-hua et al. [34] used contrast-enhanced ultraso‐
nography (CEUS) as an alternative to evaluate the implant’s vascularization, claiming it is also
effective and it is cheaper than the contrast-enhanced MRI. In order to increase the vasculari‐
zation of the implant, some authors suggest to drill an additional number of holes in the
implant where the scleral windows should be before inserting it in the cavity [35]. It is believed
that increasing the fibrovascular ingrowth in the implant will decrease its risk of migration
and extrusion. It should be emphasized that this type of implant is usually covered with donor
sclera or other materials because its rough surface easily erodes the conjunctiva when the
implant moves. This coating of the implant is useful to attach the extraocular muscles too.
There is synthetic hydroxyapatite, which is half the price of coralline hydroxyapatite. It is easier
to drill and to place the peg. There is also bovine hydroxyapatite from the cancellous bone of
calf fibulae, fully deproteinized so as to be antigen-free.
When a peg is fit into the implant, this is done 6 or more months after the surgery because this
is the time estimated for the vascularization to establish in the implant. This procedure is used
in those patients who desire to increase the prosthesis motility.
Complications related to this type of implant are discharge, pyogenic granulomas, loss of the
peg, reduced prosthesis motility, and an audible click, which can be annoying for the patient
[36]. Calcified hydroxyapatite implants are capable of absorbing radiation. This is of special
importance in children that have undergone enucleation surgery secondary to retinoblastoma,
as it hinders local recurrences and decreases the effect of secondary orbital irradiation when
needed [36-38]. Most patients are satisfied with the cosmetic outcome of the nonpegged
implant and do not desire an additional procedure with increased risks for complications.
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4.5.2. Porous Polyethylene (MEDPOR)
It is made of synthetic, high-density polyethylene powder. It is flexible and easily moldable in
order to adapt it to different shapes [39]. In contrast with hydroxyapatite, it is cheaper, it does
not need to be wrapped because the rectus muscles can be tied to it, and it is easier to place in
the orbit. Instead of using sutures, some authors have tried to fix the muscles to MEDPOR
implants with 2-ocetyl-cyanoacrylate tissue glue [40]. This proof-concept study concluded that
this technique seemed safe and had good functional and anatomical results. Porous polyethy‐
lene allows fibrovascular ingrowth, but this does not happen as fast as it does in hydroxya‐
patite. A major drawback of porous polyethylene was that there was no integrating device for
the ocular prosthesis available. Shore [41] described a titanium postcoupling system that was
included in the implant 6-12 months after the primary surgery. Generally speaking, these
implants offer excellent motility, good tolerance, and very few complications. Timoney et al.
[42] reported two cases of foreign body inflammatory giant cell reaction in patients who
underwent orbital fracture repairs with porous polyethylene implants.
4.5.3. Proplast
This is an alloplastic, biologically inert porous material. It allows fibrovascular ingrowth and
attachment of extraocular muscles.
4.5.4. Aluminum oxide
It is a porous ceramic bio-inert material, structurally strong, and free of contaminants. It is
cheaper than hydroxyapatite, and its surface is smoother. It is too biocompatible and generates
a very mild inflammatory response. It can also be wrapped in Vicryl (polyglactin 910) mesh.
5. Wrapping material
Implant covering improves the volume of the orbit and motility of the prosthesis and provides
an additional barrier for the implant. All of these are important factors for an optimal surgical
result. It is usually done in nonintegrated implants like silicone but can be used in hydroxya‐
patite too in order to protect the Tenon’s layer and the conjunctiva from the erosion of the
rough implant surface.
5.1. Donor sclera
Once warmed up to room temperature, it is advisable to send cultures of the liquid in order
to discard any possible microbiological contamination. Sclera is placed over the implant and
sutured with 4-0 or 5-0 nonabsorbable running sutures. Due to its origin, there is a small
possibility of infection transmission, including human immunodeficiency virus, hepatitis B or
C virus, and Creutzfeldt-Jakob disease. These risks have made many surgeons abandon this
wrapping material.
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5.2. Autologous tissue
This type of tissue includes temporalis fascia, dermis, human donor pericardium, fascia lata,
or posterior auricular muscle complex [43]. Their autologous origin prevents an immune host
versus graft reaction. Nevertheless, they require an extra surgical procedure to harvest them
and prepare them to cover the implant, which increases surgical time, and there is always the
risk of donor site morbidity.
5.3. Synthetic tissue
Polyglactin 910 mesh (Vicryl mesh, Ethicon, Sommerville, NJ, USA) is used to wrap hydrox‐
yapatite and bioceramic orbital implants. It offers a series of advantages: there is no risk of
disease transmission, there is no need of a second surgical site, and it is easy to use. It has a
porous structure that allows fibrovascular ingrowth [33]. Polytetrafluoroethylene and
polyglicolic acid (Dexon mesh style no8, Davis & Geck, Manati, Puerto Rico) have also been
used as implant cover materials.
Hydroxyapatite polyglactin mesh-wrapped implants [44] have been used in secondary
implants with good results both in prosthesis motility and low exposition rate.
6. Considerations in children
The anophthalmic or microphthalmic socket in children has special features that we will
discuss. One of the most important issues is that the orbit of the child should continue growing
after the eye is removed. The surgeon must have that in mind in order to achieve good cosmetic
and anatomical results. This will condition the implant selection.
The most frequent cause of enucleation in pediatric age is retinoblastoma. There has been a
special concern whether to place an implant in these orbits due to the difficulties in the follow-
up and the detection of tumor recurrence with an orbital implant in place. However, once it
was observed that orbits in children with no orbital implants did not develop appropriately,
the decision to implant was taken. Normal face and bony orbit growth depends on the orbital
soft tissue contents. When the child is five and a half years old, his face is about 90% of the size
of an adult’s face [45]. Generally talking, the management of an anophthalmic socket in a child
younger than 5 years old requires an implant that can increase in size, such as a dermis-fat
graft or orbital tissue expander. A large fixed-sized orbital implant can be placed in children
older than 5 years [46]. Orbital growth is completed by the time the child is 12-14 years old [47].
Dermis-fat grafts harvested from the thigh have shown to stimulate orbital growth in children
[48], but their motility is poor. Thus, this is an ideal implant for children younger than 5 years
old. The dermis-fat graft is also used to cover hydroxyapatite exposures and to reconstruct
sockets. A low incidence of complications has been reported with hydroxyapatite implants in
a large series of pediatric patients who had undergone enucleation surgery for different
reasons after 60 months of follow-up and excellent cosmetic results. We should not forget that
when treating an anophthalmic cavity in a child, we need to increase the conjunctival fornices,
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increase the width of the palpebral fissure promoting at the same time the eyelid growth, and
expand the orbital bones. These goals can be achieved with a good surgical implant and the
use of progressively larger conformers.
Jordan and Klapper recommend choosing the implant depending on several factors. If a child
younger than 5 years undergoes enucleation, they choose a 16-18 mm of diameter wrapped
nonporous implant (e.g., silicone). They stress that you should introduce the biggest implant
that does not create tension when closing the Tenon’s and conjunctival layers. Another option
may be dermis-fat grafts, knowing that they can reabsorb and loose some of its volume and
taking into account that the artificial eye movements will be very limited. In children aged 5-15
years, they recommend hydroxyapatite or aluminum oxide [16]. On the other hand, Shah et
al. used hydroxyapatite implants with low complication rates and good motility and high
patient/family cosmetic satisfaction on long-term follow-up in 531 orbits of children with an
average age of 3 years.
7. Postoperative complications
7.1. Anophthalmic socket complications
We can divide them depending on the surgery performed in the socket.
Patients underwent enucleation or evisceration.
7.1.1. Dryness, discharge, or irritation
Tear secretion may decrease with time [50]. Patients may be advised to use artificial tears or
gel. Saline solution can be used to clean the ocular surface. Most anophthalmic sockets have
some degree of discharge. Foreign body reaction, loss of prosthetic surface polishing, and
therefore smooth surface, abrasion of conjunctival surface, and accumulation of debris
between the prosthesis and the conjunctiva are factors that are believed to increase the
production of debris and discharge [51]. It is advisable to minimize the handling of the
prosthesis. If discharge is present, both the socket and the prosthesis should be evaluated.
Scratches and loss of luster are relatively frequent, especially if the prosthesis is old. The
ocularist usually helps with keeping the surface polished by smoothing the surface and
removing proteins and debris every 6 or 12 months. Once surface problems or inadequate fit
in the socket have been discarded, steroid or antibiotic steroid drops can be used once or twice
daily. If the discharge is mucopurulent, especially if the eyelids are swollen and conjunctival
hyperemia and chemosis is present, an infectious conjunctivitis should be considered.
Treatment should include cultures and antibiotic (quinolone) drops.
Some patients may have a giant papillary conjunctivitis, which may require steroid and
antihistamine drops. The artificial eye should be removed in the night and washed in soft
contact lens daily cleaner and denture cleaning products.
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7.1.2. Pain
Pain after eye removal is difficult to handle. If the prosthesis is correctly fit in the orbit, the
conjunctiva should be checked for any signs of inflammation or infection. If the implant
migrates anteriorly, it can compress the tissue and hurt. Pain may have its origin in the trochlea.
This can be examined by pressing on this zone. If the pain resembles that experienced by the
patient, triamcinolone injection in the trochlea can be effective [52]. Other causes or pain may
be amputation neuroma, sinus inflammation, tumor, depression, or secondary gain [53].
7.1.3. Orbital cysts
They manifest as pain or pressure sensation or even only increased difficulty to fit the artificial
eye. Cysts may grow if conjunctival epithelium is incarcerated after wound closure or when
there is epithelial ingrowth in wound dehiscence [54]. Management options are complete
surgical excision, marsupialization, absolute alcohol injection, or trichloroacetic acid (TCA)
injection [55].
7.1.4. Lower eyelid malposition
When the eye is enucleated, the disruption of the fibrous framework of the orbit may result in
the rotation of the orbital contents inferiorly and anteriorly. This will shallow the inferior fornix
and tilt the prosthesis. The inferior portion of the prosthesis pushes on the inferior eyelid, while
the superior portion moves posteriorly inside the orbit, deepening the superior sulcus. Both
of these two features are part of the anophthalmic socket syndrome, which includes an upper
eyelid ptosis, a deep superior sulcus, an enophthalmos, a lower eyelid malposition, and a fornix
retraction. With time, the lower eyelid becomes more lax, especially when heavier prosthesis
is fitted. This enhances the inferior migration of orbital tissues. The final result is a poorly
fitting artificial eye, lower eyelid malposition, shortening of the inferior fornix, and deepening
of the superior sulcus. In older patients, the laxity of the inferior eyelid increases, especially
when wearing a prosthesis even if it is not heavy.
7.2. Eyelash misdirection and entropion
Several situations are responsible for eyelash misdirection. Fornix contracture is one of the
most common due to the trauma of surgery of the eye removal or contracture as a result of
chemical burn. Sometimes the contracture of the fornix is result of the contracture of the
conjunctiva as a result of chronic inflammation. Lower eyelid laxity can also produce eyelash
misdirection. In order to correct eyelash misdirection, there are a series of options depending
on the underlying cause. When laxity of the eyelid is present, lateral canthoplasty can be a
good option. A transverse tarsal incision with marginal rotation is a simple way to change the
direction of the eyelashes. If there is a shallow fornix, a silicone band to reform the fornix is a
suitable option, but if there is a moderate to severe contraction of the fornix, fornix deepening
will require grafts that may be harvested from the hard palate, ear cartilage, or contralateral
upper lid tarsus.
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7.2.1. Ectropion
It is normally associated to lower eyelid laxity with aging in normal anophthalmic sockets.
Heavy prosthesis or frequent removal of the artificial eye will result in premature ectropion,
sometimes in very young patients. If the enucleation was due to orbital and eye trauma, skin
scars can precipitate the apparition of ectropion. When ectropion is due to eyelid laxity, lateral
tarsal strip is a good and a simple surgical option that offers good results. Heavy prosthesis
should be changed for lighter ones. Anterior lamella contraction should be treated with skin
or skin and muscle grafts and may benefit from lateral canthopexy procedures to tighten the
eyelid.
7.2.2. Ptosis
Ptosis in an anophthalmic socket is sometimes difficult to manage. Too small or too big
implants, migration of the implant, levator traumatic damage, trauma from a poorly fitted
prosthesis, trauma from the original injury, or levator aponeurosis dehiscence from the tarsal
plate can end in upper eyelid ptosis. If the implant is too small, it can be replaced for a bigger
one or volume can be increased with a dermis-fat graft. When the implant migrates inferior
and anteriorly, it can be repositioned superior and posteriorly with a subperiosteal implant.
Once the other factors have been considered and corrected if possible, a levator aponeurosis
advancement can be achieved through an anterior approach. The anterior approach will
preserve the conjunctiva from potentially contract and helps to create a symmetric eyelid
crease.
7.2.3. Deep superior sulcus and enophthalmos
Soft tissue and volume changes in the socket after enucleation or evisceration are responsible
of upper lid ptosis and lower lid laxity but also deepening of the superior sulcus. Even when
the initial surgical result may be satisfactory, with time, the implant may migrate inferior and
anteriorly, deepening the superior sulcus and making the eye socket look sunken or enoph‐
thalmic. Conservative management may include alterations in the prosthesis or wearing
glasses to camouflage the superior sulcus. Best results should be expected with surgery.
Volume augmentation with orbital floor implant placement is the first step, followed by
superior sulcus fat grafting and lower lid tightening. The last surgical procedure will be ptosis
repair.
Orbital floor implants placed subperiosteally are indicated if the implant is of adequate size
and in position. Different materials such as acrylic (polymethylmethacrylate), bone grafts,
hydroxyapatite, autogenous fat, injectable hydroxyapatite, dermis-fat grafts, and others have
been used. Polymethylmethacrylate is a well-tolerated material placed subperiosteally using
a swinging eyelid technique. This implant displaces the orbital implant and surrounding
connective tissue and fat anterior and superiorly, thus reducing the sunken superior sulcus. If
there is a residual defect after this surgery or when the defect of the superior sulcus is mild or
when the patients rejects the placement of a subperiosteal implant, the superior sulcus can be
filled with a dermis-fat graft or with an autologous fat graft or a dermal filler such as hyaluronic
acid [56]
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7.2.4. Implant exposure or extrusion
They are the most frequent complications reported in the literature. They can happen with any
kind of implant and at any time. There are many factors involved, including incorrect closure
of the wound, infections, implant too large for the socket, bad prosthesis adaptation, or delayed
fibrovascular ingrowth.
Exposures in the first 3 months after the surgery are probably due to poor wound healing or
surgical closure or incorrect position of the orbital implant. Once again, we would like to
highlight the importance of a correct tension-free closure of Tenon’s layer. Exposures occurring
3 months to 1 year after surgery can be due to the factors previously reported and others like
infection or inflammatory response. When exposures occur beyond the first 2 years, they are
usually due to mechanical factors such as friction or pressure from the prosthesis [57].
If a nonporous implant exposition is acute and not too big, it can be solved with prompt medical
or surgical treatment, but when the exposition is big (more than 3 mm) or long lasting (4 months
or more), it usually leads to implant extrusion and, therefore, to its removal. On the other hand,
exposed porous implants generally do not extrude because of their fibrovascular anchorage
in the socket [58]. Although some porous implants can expose 10 years after surgery, most of
the exposures take place within the first year after the surgery. As mentioned above, the use
of materials that cover porous implants is an attempt to reduce implant exposition when the
surface of the implant is rough enough to rub and tear the conjunctiva. However, Suter et al.
[59] have suggested that this kind of material could produce the contrary effect as it would act
as a barrier to fibrovascular ingrowth. Kamai et al. [60] used 20% autologous serum when there
was conjunctival postoperative dehiscence and necrosis with good results. They recommend
to put a drop at least 10 times a day. They observed that the healing occurred after 2 weeks of
autologous serum use, preventing the exposure of the implant. Quaranta-Leoni et al. [61] found
the presence of Gram-positive cocci infection in 59% of the patients in a group of 25 people
when the porous orbital implants were exposed requiring explantation. A histopathological
examination showed the presence of a chronic inflammatory infiltrate in 22 implants (88%)
and significantly reduced fibrovascular ingrowth of the implant in all patients. They consid‐
ered a good surgical option the implantation of a dermis-fat graft in the socket once explanted
the implant in order to address the volume deficit following implant removal.
There are many surgical options to treat exposed implants: scleral patch grafts [62], mucous
membrane grafts [63], temporalis fascia grafts [64], conjunctival pedicle grafts [65], and dermis-
fat grafts [66]. Chu et al. [67] proposed a triple layer to treat exposed implants: donor sclera,
muscle flaps, and oral mucosa.
7.2.5. Socket contracture
The patient will complain that the prosthesis keeps falling out of the socket. Acquired socket
contraction is the consequence of shrinkage and shortening of some or all of the tissues of the
anophthalmic orbit; thus, the fornices are not able to retain the prosthesis. In order to prevent
it, it is mandatory to carry out a straightforward enucleation or evisceration surgery that is,
taking care to keep trauma to the conjunctiva, connective tissue, and orbital at minimum levels.
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Fornices should not be undermined, and cauterization should be minimized by using gauzes
soaked in freezing water and using the bipolar cautery with low energy levels. The conformer
should be fit in the socket once the surgery is finished and kept in place until a nondefinite
artificial eye is fitted [68]. The more surgeries a socket undergoes, the bigger the risk of
developing a socket contracture. In order to simplify its management, we can classify it into
the following:
Mild socket contracture. When the posterior lamella shortens, the lashes rotate inward and
entropion develops. There is a decrease of the inferior fornix causing a prolapse of the inferior
pole of the prosthesis. A transverse tarsal incision with marginal rotation is the initial treatment
of choice [69]. There is usually a lower eyelid horizontal laxity too. When there is enough
conjunctiva, a lateral canthal tendon procedure associated to a fornix reformation procedure
should be performed. The fornix is reformed using 3-0 or 4-0 polyglactin sutures anchored to
the periorbita and skin tied over a bolster [70]. However, if there is a lower lid contraction, a
posterior lamella lengthening procedure is the best option. Several autogenous spacer grafts
have been used: fascia lata, oral mucosa [71], nasal cartilage, hard palate, upper eyelid tarsus,
or auricular cartilage [72]. Auricular cartilage is easy to harvest, provides support for the
artificial eye, lengthens the posterior lamella, and prevents forward tilt of the prosthesis [73].
Oral mucosa is an excellent option to increase the mucous surface but lacks supportive
properties.
Moderate socket contracture. One or both of the fornices are contracted. Typically, the first to
contract is the inferior fornix. When the superior fornix contracts, the artificial eye may be
retained but the eyelid excursion may be very limited. The gold standard for the treatment of
moderate socket contracture is mucous membrane grafting, usually obtained from oral (lip)
or buccal (cheek) mucosa [74,75]. Grafts undergo shrinkage with time, so a graft harvested 40%
bigger than the defect is recommended. The conjunctiva is undermined, and the graft is
sutured with absorbable 7-0 interrupted sutures. A retinal band can be used to reform the
inferior and upper fornices, anchoring it to the periorbita and the skin with bolsters. Then a
conformer is placed. Amniotic membrane has also been used as a graft with good results.
If the patient has a socket volume deficiency associated to the socket contracture, the patient
will improve with a dermis-fat graft [76], increasing the orbital volume and the conjunctival
surface area.
Severe socket contracture. The conjunctival fornices are nearly or completely obliterated, and the
prosthesis may fall constantly or give the patient a “staring” appearance. It is frequent to have
discharge and irritation or even an active inflammation. The goal of the surgery is to make the
patient comfortable and have a good cosmesis. The patient may need to undergo several
surgeries with buccal mucosa grafts and flaps from temporalis muscle or radial forearm. When
results are very poor, some patients may benefit from an exenteration procedure, which may
improve the aesthetics and the comfort of the socket.
Patients underwent exenteration.
Eye Removal — Current Indications and Technical Tips
http://dx.doi.org/10.5772/61030
55
7.3. Exenterated orbit
7.3.1. Sino-orbital fistula
Its frequency has been reported to be as high as 68% [77] and as low as 28% [78]. It is more
common when the orbit is left to granulate rather than when a skin graft is used.The majority
affect the ethmoid sinus. Risk factors are surgical trauma to the ethmoid or lacrimal bones,
sinus disease, radiotherapy, and immunocompromised. They can lead to ethmoidal sinusitis.
Management ranges from conservative socket hygiene to surgical repair with flaps or grafts,
but it is not unusual for the fistula to recur [79].
7.3.2. Chronic discharge
Once healed, if the socket has a sino-orbital fistula, pus from the ethmoid sinus can drain to
the orbit when sinusitis is present. In these cases, systemic antibiotics like third-generation
cephalosporin twice daily for 14 days may be enough. If medical treatment is not curative, the
patient may be referred to the head and neck surgeon in order to program the patient for
endoscopic sinus drainage surgery.
The skin coating the orbit will need to be cleaned with soap and water, just as any other part
of the body. Sometimes patients are reticent to let anyone do this for them and it is relatively
frequent to find dirty skin in the orbit.
7.3.3. Cerebrospinal fluid leak
A cerebrospinal fluid (CSF) leak may lead to meningitis, delayed cerebral abscess, seizures,
CSF hypotension with position-dependent headache syndrome, occult hemorrhage, and even
death [80]. The incidence reported by an Australian team was 0.6% [81]. However, it can be as
high as 29% [82]. Interestingly, the intraoperative use of monopolar cautery in areas of thin
orbital bone may contribute to the incidence of CSF leaks [83]. Once you detect clear liquid
leaking from the bone in areas of high risk of encountering dura, prompt treatment usually
ends in good results. It is very advisable to consult the neurosurgery team. A dural laceration
can be sutured with 5-0 or 6-0 polyglactin or nylon to create a watertight seal. If the defect is
large, an autologous graft (fat, temporalis muscle or fascia, and pericranium) and a tissue
adhesive such as human fibrinogen and bovine thrombine or cyanoacrylate [84] can be used.
In smaller defects, tissue adhesives may be enough to seal the leak. Additional materials used
in the repair of CSF leaks at other sites include the use of gelfoam® in epidural blood patches.
At the end, packing material can be placed in the socket to hold the plug of muscle or fascia
against the defect and therefore protect from further leakage. After surgery, the patient must
avoid blowing his or her nose and coughing as well as physical activity. Acetazolamide is used
to reduce the production of CSF in order to treat CSF leaks. Some authors use systemic
antibiotics when there is an intraoperative leak of CSF, but many believe they are unnecessary
to prevent meningitis [85].
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7.3.4. Delayed healing
The orbital defect left to heal spontaneously once exenterated will granulate slowly if allowed
only to grow from the orbital rim, and it will heal faster when it heals from spared eyelids.
Nevertheless, this will take at least 2-3 months more than when the defect is covered by a
temporalis muscle transposition [86], dermis-fat graft (in subtotal exenteration), or split skin
graft [87]. Healing by granulation has shorter operating room time and allows for better clinical
monitoring of recurrence. However, it requires frequent visits to change the dressings [88],
every week and sometimes every 2 or 3 days, and may delay other therapeutic procedures
such as radiotherapy. Depending on how the granulation process is developing, dressings may
need to be associated to hydrogel mesh or silver mesh. Orbital obliteration with temporalis
muscle or a graft may induce less pain, improve personal hygiene, and reduce the risk of sino-
orbital fistula, but it requires image techniques such as MRI, CT, or PET to detect local
recurrences.
7.3.5. Tumor recurrence
Tumor recurrence following orbital exenteration can occur in 24-45% of cases [82,89]. Early
detection of tumor recurrence in patients who have undergone orbital exenteration is very
important. This task is relatively easy when the orbit was left to granulate, but it is difficult
when the normal anatomical landmarks have been lost (like when exenteration is associated
to ethmoidectomy), and there are flaps covering large cavities. Recurrent tumors may appear
as soft tissue similar to the primary tumor, especially in the first 2 years of the surgery (65%
of the cases) and in the margin of the flap [90]. Lee et al. recommend to follow this patients
with frequent MRI, at least every 4 months after surgery for the 2 first years and every 6 months
for 3 more years. On MRI, recurrences appear on the margin of the flap and are often T2
isointense, as opposed to the hyperintense appearance described in normal flaps. PET has also
been used to help to differentiate recurrence from scarring or radiation-associated tissue
changes.
8. Conclusions
The removal of the eye in any surgical variants (enucleation, evisceration, and exenteration)
requires a careful and thorough planning process. A detailed patient explanation of the causes
that have led to this type of surgery is mandatory as a breakdown of the consequences of the
operation. These explanations should be extended to the family as the immediate aesthetic
impact not only affects the patient. Once the most appropriate surgical technique has been
chosen, it should be planned in detail beforehand, including potential needs for collaboration
with other surgical specialties such as plastic surgery, maxillofacial surgery, neurosurgery, or
otolaryngology. It is also important to have the support of anesthesiology for good intraoper‐
ative monitoring of the patient. The surgical procedure must be done with thoroughness and
patience since the surgical time is long in many cases, and rigorous performance of the surgical
steps is one factor that decreases the rate of complications. In cases where an implant is
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required, this can be carried out in a primary or secondary way. The advantages and disad‐
vantages of different types of implants and the use of wrapping material is widely discussed
with the patient. It is important to emphasize the patient-recovering milestones and possible
postoperative complications as well as the need for other secondary surgical techniques, e.g.,
eyelid surgery. Postoperative follow-up is crucial to detect and treat complications as early as
possible. Finally, we would like to stress that collaboration with the ocularist is essential in
order to get a good adaptation of the prosthesis and aesthetical patient satisfaction.
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